Kowa Pharmaceuticals America, Inc., headquartered in Montgomery, Alabama, is focused primarily in the area of cardiometabolic diseases. Established in 2008, KPA focuses its efforts on the successful commercialization of its current and near-term portfolio of pharmaceutical products and business development activities.
